Gerald R. Chan

Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.